Thyroid C-cell Tumors: In rodent studies, semaglutide continues to be revealed to bring about thyroid C-mobile tumors. It is not known no matter if this risk applies to human beings, but semaglutide is contraindicated in individuals with a private or relatives heritage of medullary thyroid carcinoma